| MiRNA | Compound | Condition | Effect | Throughput | PMID | Details |
|---|---|---|---|---|---|---|
| miR-181a | Cisplatin | Non-small Cell Lung Cancer | Resistant | High | 21787234 | |
| miR-181a | Cisplatin | adenocarcinoma | Resistant | Low | 23137650 | |
| miR-181a | Cisplatin | lung cancer | Resistant | Low | 23137650 | |
| miR-181a* | Cisplatin | adenocarcinoma | Resistant | Low | 23137650 | |
| miR-181a* | Cisplatin | lung cancer | Resistant | Low | 23137650 | |
| miR-181a | Cisplatin | hepatocellular cancer | Resistant | High | 23229111 | |
| miR-181a | Cisplatin | squamous cell carcinoma | Resistant | High | 23831023 | |
| miR-181a | Cisplatin | tongue squamous cell carcinoma | Sensitive | Low | 24148247 | |
| miR-181a | Cisplatin | cervical squamous cell carcinoma | Resistant | Low | 24183997 | |
| miR-181a | Cisplatin | ovarian cancer | Resistant | Low | 24394555 | |
| miR-181a | Cisplatin | esophageal adenocarcinoma | Sensitive | High | 25356050 | |
| miR-181a | Cisplatin | ovarian cancer | Sensitive | High | 26043084 | |
| miR-181a | Cisplatin | lung adenocarcinoma | Associated | Low | 26323677 | |
| miR-181a | Cisplatin | gastric cancer | Sensitive | Low | 26589846 | |
| miR-181a-2 | Cisplatin | small cell lung cancer | Sensitive | High | 26676926 |